SmallCapReview.com has been a leading site for information on small cap stocks, penny stocks and microcaps since 1999.
Biostar Pharmaceuticals (Nasdaq: BSPM) $2.22. Today announced financial results for the fourth quarter and full year ended December 31, 2010. Revenue for the fourth quarter of 2010 increased 65.7% to approximately $28.2 million compared to $17.1 million for the fourth quarter of 2009.
Net income was approximately $6.1 million for the fourth quarter of 2010, a 259% increase from the fourth quarter of 2009. Diluted earnings per share were $0.22 and 0.07 for the fourth quarter of 2010 and 2009, based upon 27.4 million and 24.3 million diluted common stocks outstanding, respectively. Adjusted Non-GAAP net income for the fourth quarter was $6.3 million, or $0.24 per diluted common share.
What They Do: Biostar Pharmaceuticals, Inc., through its wholly-owned subsidiary and controlled affiliate in China, develops, manufactures and markets pharmaceutical and health supplement products for a variety of diseases and conditions.
ServiceSource (Nasdaq: SREV) Priced at $10.00. Today announced it will visit the NASDAQ MarketSite in New York City's Times Square to celebrate their initial public offering on The NASDAQ Stock Market which takes place today, March 25, 2011. In honor of the occasion Mike Smerklo, Chairman and CEO of ServiceSource (SREV), will ring the Opening Bell.
What They Do: ServiceSource partners with technology--based companies to help them maximize maintenance, support and subscription revenue while optimizing customer loyalty.
About SmallCapReview
Copyright SmallCapReview. SmallCapReview.com is a leading site for news on small-caps, penny stocks and microcaps. SmallCapReview has built a loyal opt-in following for their investor products by providing a newsletter at no cost, sent to subscribers, highlighting select stocks in play, to register visit www.SmallCapReview.com.
